Literature DB >> 33182876

Large area liquid crystal lenses for correction of presbyopia.

Afsoon Jamali, Douglas Bryant, Amit K Bhowmick, Philip J Bos.   

Abstract

Presbyopia is the failure of the eye lens to accommodate. The widely used presbyopia correction method involves wearing bi/trifocal or progressive glasses, which limits the field of view due to division of lens area into sections of different optical power. A large aperture focus tunable liquid crystal lens has the potential to correct human eye accommodation failure and provide a wide field of view. In this paper, we present characterization and demonstration of a segmented phase profile liquid crystal lens, which has the characteristics of a large area (diameter: 20 mm), being flat and thin (<2 mm), and having continuous focus tunability (1.5 D to 0 D), fast response time (<500 ms), low operating voltage (<5 V), and on-axis diffraction-limited performance (for a 5mm aperture). Considering all these properties, our lens provides performance details of an approach for presbyopia correction. We have tested the minimum resolution and visual acuity of 20 subjects using the designed lens and compared the results with a reference glass lens of the same optical power.

Entities:  

Year:  2020        PMID: 33182876     DOI: 10.1364/OE.408770

Source DB:  PubMed          Journal:  Opt Express        ISSN: 1094-4087            Impact factor:   3.894


  3 in total

Review 1.  Liquid Crystal Devices for Beam Steering Applications.

Authors:  Rowan Morris; J Cliff Jones; Mamatha Nagaraj
Journal:  Micromachines (Basel)       Date:  2021-02-28       Impact factor: 2.891

2.  Controllable shifting, steering, and expanding of light beam based on multi-layer liquid-crystal cells.

Authors:  Urban Mur; Miha Ravnik; David Seč
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.996

Review 3.  Electrically Tunable Lenses: A Review.

Authors:  Leihao Chen; Michele Ghilardi; James J C Busfield; Federico Carpi
Journal:  Front Robot AI       Date:  2021-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.